切换至 "中华医学电子期刊资源库"
高级检索
中华肾病研究电子杂志

中华肾病研究电子杂志 ›› 2018, Vol. 07 ›› Issue (03) : 122 -125. doi: 10.3877/cma.j.issn.2095-3216.2018.03.006

所属专题： 文献；

论著

氨甲酰化促红细胞生成素对慢性肾衰竭合并急性肾损伤大鼠肾脏的保护作用
梅艳1, 洪权1, 马倩1, 张杰1, 谢院生1, 蔡广研1, 陈香美1,†()   
  1. 1. 100853　北京，解放军总医院肾脏病科、解放军肾脏病研究所、肾脏疾病国家重点实验室、国家慢性肾病临床医学研究中心
  • 收稿日期:2018-01-17 出版日期:2018-06-28
  • 通信作者: 陈香美
  • 基金资助:
    国家自然科学基金(81470949，81670671，82473531); 国家科技支撑计划(2015BAI12B06)

Renal protective effects of carbamylated erythropoietin in chronic renal failure rats complicated with acute kidney injury

Yan Mei1, Quan Hong1, Qian Ma1, Jie Zhang1, Yuansheng Xie1, Guangyan Cai1, Xiangmei Chen1,†()   

  1. 1. Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing 100853, China
  • Received:2018-01-17 Published:2018-06-28
  • Corresponding author: Xiangmei Chen
  • About author:
    Corresponding author: Chen Xiangmei, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

梅艳, 洪权, 马倩, 张杰, 谢院生, 蔡广研, 陈香美. 氨甲酰化促红细胞生成素对慢性肾衰竭合并急性肾损伤大鼠肾脏的保护作用[J/OL]. 中华肾病研究电子杂志, 2018, 07(03): 122-125.

Yan Mei, Quan Hong, Qian Ma, Jie Zhang, Yuansheng Xie, Guangyan Cai, Xiangmei Chen. Renal protective effects of carbamylated erythropoietin in chronic renal failure rats complicated with acute kidney injury[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2018, 07(03): 122-125.

目的

观察氨甲酰化促红细胞生成素(carbamylated erythropoietin, CEPO)对慢性肾脏病(CKD)合并急性肾损伤(AKI)大鼠模型的肾脏保护作用。

方法

取健康雄性SD大鼠(450±20 g)39只，随机分为3组，首先制作5/6肾切除大鼠慢性肾衰模型，10 d后确认大鼠慢性肾衰竭模型造模成功。在该慢性肾衰竭模型大鼠双后肢肌肉按照8 ml/kg的剂量注射50%甘油制作合并急性肾损伤模型。第11，12，13天向各组注射：生理盐水(NS)组：腹腔注射生理盐水；促红细胞生成素(EPO)组：按照5 000 U/kg的剂量向大鼠腹腔内注射EPO；CEPO组：按照5 000 U/kg的剂量进行腹腔注射CEPO。在第1，5，10，11，13，17天对大鼠的体重、血压进行检测，同时尾静脉采血对红细胞比容、血肌酐、尿素氮进行检测，留取肾组织进行病理学PAS检测。用SPSS 19.0统计软件对实验数据进行统计学处理，P<0.05被认为差异有统计学意义。

结果

与生理盐水注射组比较，CEPO组和EPO组可缓解大鼠体重的减轻幅度(F＝8.19，F＝6.84, P<0.05)，可保护大鼠肾功能，降低大鼠血肌酐(F＝5.12, F＝13.72, P<0.05)和血尿素(F＝4.63，F＝12.78, P<0.05)的水平，减轻肾脏小管病理损伤(F＝9.14, F＝12.73, P<0.05)，并且CEPO组能显示出更明显的作用(P<0.05)，CEPO相对于EPO能够缓解升高红细胞比容的副作用(F＝8.27, P＝0.019)。

结论

CEPO对CKD合并AKI模型大鼠能起到明显的肾脏保护作用，并且相对于EPO治疗能降低引起红细胞比容升高的副作用。

关键词: 慢性肾脏疾病, 急性肾损伤, 氨甲酰化促红细胞生成素
Objective

To observe the renal protective effects of carbamylated erythropoietin (CEPO) in rats with chronic kidney disease (CKD) complicated with acute kidney injury (AKI).

Methods

Thirty-nine healthy male SD rats (450±20 g) were randomly divided into three groups. Firstly, the model of chronic renal failure was made by 5/6 nephrectomy in rats, and was confirmed 10 days later. Afterwards, the model of complicated AKI was made by injection in the hind limb muscle with 50% glycerol at a dose of 8 ml/kg. On the 11th, 12th, and 13th day, each group was treated with intraperitoneal injection of normal saline (NS group), erythropoietin at a dose of 5 000 U/kg (EPO group), and CEPO at a dose of 5 000 U/kg (CEPO group). On the 1st, 5th, 10th, 11th, 13th, and 17th day, the body weight and blood pressure of the rats were detected. At the same time, blood from the tail vein was used to detect hematocrit, serum creatinine, and urea nitrogen, and the renal tissues were taken for pathological periodic acid-Schiff (PAS) staining. The experimental data were processed with SPSS 19.0 statistical software. P<0.05 was considered statistically significant.

Results

Compared with the NS group, the CEPO group and the EPO group relieved the weight loss of rats (F=8.19, F=6.84, P<0.05), reduced the levels of Scr (F=5.12, F=13.72, P<0.05)and BUN (F=4.63, F=12.78, P<0.05), and reduced the renal tubular pathological damage (F=9.14, F=12.73, P<0.05). The CEPO group′s effects were more obvious than those of the EPO group (P<0.05). And CEPO relieved the increase of hematocrit, the side effect of EPO(F=8.27, P=0.019).

Conclusions

CEPO showed significant renal protective effects in the CKD rat model complicated with AKI. The CEPO treatment could also reduce the increased level of hematocrit.

Key words: Chronic kidney disease, Acute kidney injury, Carbamylated erythropoietin
图1 A：术后不同时间各组大鼠血肌酐水平。与NS组比较，aP<0.05；与EPO组比较，bP<0.05；NS：生理盐水组；EPO：EPO注射组；CEPO：CEPO注射组；每组n≥6; B：术后不同时间各组大鼠血尿素氮水平。与NS组比较，aP<0.05；与EPO组比较，bP<0.05；NS：生理盐水组；EPO：EPO注射组；CEPO：CEPO注射组；每组n≥6
图2 术后不同时间各组大鼠红细胞比容水平
图3 术后各组大鼠肾脏病理表现(PAS×400)
[1]
Zuk A, Bonventre JV. Acute kidney injury: can remote ischaemic preconditioning prevent AKI? [J]. Nat Rev Nephrol, 2015, 11(9): 512-513.
[2]
Doi K, Rabb H. Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets [J]. Kidney Int, 2016, 89(3): 555-564.
[3]
Collister D, Komenda P, Hiebert B, et al. The effect of erythropoietin-stimulating agents on health-related quality of life in anemia of chronic kidney disease: a systematic review and meta-analysis [J]. Ann Intern Med, 2016, 164(7): 472-478.
[4]
Chen J, Yang Z, Zhang X. Carbamylated erythropoietin: a prospective drug candidate for neuroprotection [J]. Biochem Insights, 2015, 8(Suppl 1): 25-29.
[5]
Deak AT, Troppan K, Rosenkranz AR. Anemia management in cancer patients with chronic kidney disease [J]. Eur J Intern Med, 2016, 36: 13-19.
[6]
Brines M, Cerami A. Discovering erythropoietin′s extra-hematopoietic functions: biology and clinical promise [J]. Kidney Int, 2006, 70(2): 246-250.
[7]
Ocmen E, Derbent A, Micilli SC, et al. Erythropoietin diminishes isoflurane-induced apoptosis in rat frontal cortex [J]. Paediatr Anaesth, 2016, 26(4): 444-451.
[8]
Leist M, Ghezzi P, Grasso G, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic [J]. Science, 2004, 305(5681): 239-242.
[9]
Geng X, Wang Y, Hong Q, et al. Differences in gene expression profiles and signaling pathways in rhabdomyolysis-induced acute kidney injury [J]. Int J Clin Exp Pathol, 2015, 8(11): 14087-14098.
[10]
Geng XD, Zheng W, Wu CM, et al. Embryonic stem cells-loaded gelatin microcryogels slow progression of chronic kidney disease [J]. Chin Med J (Engl), 2016, 129(4): 392-398.
[1] 张婧琦, 江洋, 孙佳璐, 唐兴喆, 赵宇飞, 崔颖, 李信响, 戴景月, 傅琳, 彭新桂. 基于肾周CT特征结合血清肌酐水平探讨脓毒症伴急性肾损伤的早期识别[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 285-292.
[2] 樊恒, 孙敏, 朱建华. 红景天苷通过抑制PI3K/AKT/mTOR信号通路对大鼠脓毒症急性肾损伤的保护作用[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(03): 188-195.
[3] 张锦丽, 席毛毛, 褚志刚, 栾夏刚, 陈诺, 王德运, 谢卫国. 大面积烧伤患者发生早期急性肾损伤的危险因素分析[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 282-287.
[4] 彭瑞, 杨瑞文, 魏澹宁, 夏永良. 琥珀酸受体1加重肾脏缺血再灌注损伤的作用研究[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 159-164.
[5] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 中国肝移植受者肾损伤管理临床实践指南（2023版）[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 276-288.
[6] 杜霞, 马梦青, 曹长春. 造影剂诱导的急性肾损伤的发病机制及干预靶点研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 279-282.
[7] 郭俊楠, 林惠, 任艺林, 乔晞. 氨基酸代谢异常在急性肾损伤向慢性肾脏病转变中的作用研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 283-287.
[8] 袁楠, 黄梦杰, 白云凤, 李晓帆, 罗从娟, 陈健文. 急性肾损伤-慢性肾脏病转化小鼠模型制备的教学要点及学习效果分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 226-230.
[9] 林玲, 李京儒, 沈瑞华, 林惠, 乔晞. 基于生物信息学分析小鼠急性肾损伤和急性肺损伤的枢纽基因[J/OL]. 中华肾病研究电子杂志, 2024, 13(03): 134-144.
[10] 周建芳, 罗旭颖, 张琳琳, 李宏亮, 杨燕琳, 陈光强, 石广志. 开颅术后危重患者急性肾损伤的发病率、危险因素及其对预后的影响[J/OL]. 中华重症医学电子杂志, 2024, 10(02): 148-156.
[11] 肖增丽, 杜安琪, 孙瑶, 赵慧颖, 安友仲. 脑出血术后AKI发生的危险因素分析及预测模型建立[J/OL]. 中华重症医学电子杂志, 2024, 10(02): 157-163.
[12] 司楠, 孙洪涛. 创伤性脑损伤后肾功能障碍危险因素的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 300-305.
[13] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[14] 崔秋子, 姚红曼, 艾迎春. 监测NLR、PLR、CAR、白蛋白、血钙及血糖指标水平对急性胰腺炎患者急性肾损伤的预测价值分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 244-248.
[15] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号